用户名: 密   码:
注册 | 忘记密码?
专利信息
查询条件 展开筛选条件
  • [专利权人] 包含 'Aptalis Pharmatech, Inc.'
  • [药品] 包含 'Propranolol'
排序 翻到页码
标题标题2专利权人发明人附图摘要摘要2优先权号IPC专利类型
首页1尾页5 条记录, 当前第1/1页。
公开号 公开日 申请号 申请日
1. US8367111B2 2013/2/5 US10/335295 2002/12/31
专利标题:Extended release dosage forms of propranolol hydrochloride 法律状态
专利权人Aptalis Pharmatech, Inc.;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a sustained release fashion similar to that produced by INDERAL® LA indicated for the treatment of cardiovascular diseases comprises two populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid release profile (i.e. substantially complete release within 60 minutes) or sustained release profile over a period of 24 hours. Such a cardiovascu...


2. US20060269607A1 2006/11/30 US11/500892 2006/8/9
专利标题:Timed, sustained release systems for propranolol 法律状态
专利权人Aptalis Pharmatech, Inc.;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a circadian release fashion is comprising of one or more populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid or sustained release profile with or without a predetermined lag time of 3 to 5 hours. Such a circadian rhythm release cardiovascular drug delivery system is designed to provide a plasma concentration-time profile which varies...


3. US20040126427A1 2004/7/1 US10/335295 2002/12/31
专利标题:Extended release dosage forms of propranolol hydrochloride 法律状态
专利权人Aptalis Pharmatech, Inc.;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a sustained release fashion similar to that produced by INDERAL LA indicated for the treatment of cardiovascular diseases comprises two populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid release profile (i.e. substantially complete release within 60 minutes) or sustained release profile over a period of 24 hours. Such a cardiovascul...


4. US20040047906A1 2004/3/11 US10/453848 2003/6/2
专利标题:Timed, sustained release systems for propranolol 法律状态
专利权人Aptalis Pharmatech, Inc.;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a circadian release fashion is comprising of one or more populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid or sustained release profile with or without a predetermined lag time of 3 to 5 hours. Such a circadian rhythm release cardiovascular drug delivery system is designed to provide a plasma concentrationtime profile which varies ...


5. US20030157173A1 2003/8/21 US10/334052 2002/12/30
专利标题:Timed, sustained release systems for propranolol 法律状态
专利权人Aptalis Pharmatech, Inc.;
A unit dosage form such as a capsule or the like for delivering drugs into the body in a circadian release fashion is comprising of one or more populations of propranolol-containing particles (beads pellets granules etc.). Each bead population exhibits a pre-designed rapid or sustained release profile with or without a predetermined lag time of 3 to 5 hours. Such a circadian rhythm release cardiovascular drug delivery system is designed to provide a plasma concentrationtime profile which varies ...



首页1尾页5 条记录, 当前第1/1页。

下载范围

下载第 条记录。

下载内容

题录信息 专利全文